marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Greenlane Holdings, Inc. (GNLN) Announces Leadership Changes and Plans to Capitalize Business and Accelerate Path to Profitability

Greenlane Announces Leadership Changes and Plans to Capitalize Business and Accelerate Path…

TerrAscend Corp. (TRSSF) to Delight NJ Shoppers with an Immersive Cookies Experience

TerrAscend to Delight NJ Shoppers with an Immersive Cookies Experience TerrAscend Corp.…

Endexx Corporation (EDXC) Announces Investment in EcoHealth Neuropathy Inc.

Endexx Announces Investment in EcoHealth Neuropathy Inc. Endexx Corporation (OTC PINK: EDXC),…

Canopy Growth Corporation (CGC) to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results…